Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 2.36 billion. The enterprise value is 3.49 billion.
| Market Cap | 2.36B |
| Enterprise Value | 3.49B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
Synbio Tech has 34.48 million shares outstanding. The number of shares has increased by 5.79% in one year.
| Current Share Class | 34.48M |
| Shares Outstanding | 34.48M |
| Shares Change (YoY) | +5.79% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 22.30% |
| Owned by Institutions (%) | n/a |
| Float | 17.79M |
Valuation Ratios
The trailing PE ratio is 12.97.
| PE Ratio | 12.97 |
| Forward PE | n/a |
| PS Ratio | 2.27 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.57, with an EV/FCF ratio of -6.23.
| EV / Earnings | 19.83 |
| EV / Sales | 3.36 |
| EV / EBITDA | 12.57 |
| EV / EBIT | 17.60 |
| EV / FCF | -6.23 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.05.
| Current Ratio | 1.20 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 5.04 |
| Debt / FCF | -2.50 |
| Interest Coverage | 15.61 |
Financial Efficiency
Return on equity (ROE) is 14.61% and return on invested capital (ROIC) is 7.31%.
| Return on Equity (ROE) | 14.61% |
| Return on Assets (ROA) | 4.56% |
| Return on Invested Capital (ROIC) | 7.31% |
| Return on Capital Employed (ROCE) | 8.11% |
| Weighted Average Cost of Capital (WACC) | 6.85% |
| Revenue Per Employee | 11.29M |
| Profits Per Employee | 1.91M |
| Employee Count | 92 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, Synbio Tech has paid 26.40 million in taxes.
| Income Tax | 26.40M |
| Effective Tax Rate | 13.04% |
Stock Price Statistics
The stock price has decreased by -8.67% in the last 52 weeks. The beta is 1.13, so Synbio Tech's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -8.67% |
| 50-Day Moving Average | 78.96 |
| 200-Day Moving Average | 103.93 |
| Relative Strength Index (RSI) | 30.80 |
| Average Volume (20 Days) | 82,152 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.04 billion and earned 175.97 million in profits. Earnings per share was 5.28.
| Revenue | 1.04B |
| Gross Profit | 555.20M |
| Operating Income | 198.26M |
| Pretax Income | 202.36M |
| Net Income | 175.97M |
| EBITDA | 277.49M |
| EBIT | 198.26M |
| Earnings Per Share (EPS) | 5.28 |
Balance Sheet
The company has 269.94 million in cash and 1.40 billion in debt, with a net cash position of -1.13 billion or -32.71 per share.
| Cash & Cash Equivalents | 269.94M |
| Total Debt | 1.40B |
| Net Cash | -1.13B |
| Net Cash Per Share | -32.71 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 38.52 |
| Working Capital | 130.31M |
Cash Flow
In the last 12 months, operating cash flow was 143.35 million and capital expenditures -703.07 million, giving a free cash flow of -559.72 million.
| Operating Cash Flow | 143.35M |
| Capital Expenditures | -703.07M |
| Depreciation & Amortization | 79.23M |
| Net Borrowing | 422.56M |
| Free Cash Flow | -559.72M |
| FCF Per Share | -16.24 |
Margins
Gross margin is 53.45%, with operating and profit margins of 19.09% and 16.94%.
| Gross Margin | 53.45% |
| Operating Margin | 19.09% |
| Pretax Margin | 19.48% |
| Profit Margin | 16.94% |
| EBITDA Margin | 26.72% |
| EBIT Margin | 19.09% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 5.03%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 5.03% |
| Dividend Growth (YoY) | -39.64% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 62.36% |
| Buyback Yield | -5.79% |
| Shareholder Yield | -0.81% |
| Earnings Yield | 7.45% |
| FCF Yield | -23.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 1.97 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 3 |